Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07147023

Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication

The goal of this study is to test the accuracy of Large Language Model-generated serious illness communication (SIC) summaries, the feasibility of delivering the SIC summaries, and to collect perspectives on the SIC summaries from clinicians and participants with cancer. Large Language Models (LLMs) are artificial intelligence programs that can perform various natural language processing tasks.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brigham and Women's Hospital, Boston, Massachusetts, United States

Loading trial locations.

About this study

The study will enroll up to 70 Dana-Farber patients admitted to Brigham and Women's hospital who have an elevated mortality prediction at admission. The research study procedures include randomization to intervention or control arms on admission (3:1 intervention to control). For patients in the intervention arm, a large language model query will summarize serious illness communication documentation in their medical record screening from the prior 6 months. A summary of the documentation will be sent to the inpatient and outpatient oncology clinicians within 24 hours of admission; these clinicians will be asked to review the summaries, discuss with the patient and incorporate into care plans as appropriate. For patients with no SIC documented on day 4 of the admission, a second email will be sent. Control patients will receive usual care, which is no email sent to their oncology teams. All patients will be offered to participate in an interview on day 4 of their admission about their communication with their care teams. For patients in both arms, inpatient and outpatient oncology attendings will be sent an email survey regarding SIC for the patient and, if applicable, the utility of the SIC summaries.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Participant Inclusion Criteria:

  • Dana-Farber Cancer Institute participants
  • Admission to an inpatient solid tumor medical oncology service at BWH (including beds that are considered to be DFCI beds within BWH)
  • Age ≥ 18 years
  • Mortality prediction ≥ 40%
  • Admitted on a Sunday after 4pm, Monday or Tuesday before 4pm. These time restrictions are necessary for the workflow of this pragmatic pilot trial, as an individual will need to send out the intervention emails and interview patients approximately 48-72 hours after admission, both of which need to occur during the work week.

Participant Exclusion Criteria:

-Patients with elective inpatient admissions (typically for chemotherapy or other treatments)

Clinician Inclusion Criteria:

-The clinician fills one of the following roles for the enrolled patient:

  • inpatient attending on the medical oncology team
  • outpatient Dana-Farber medical oncologist

Treatment and study plan

LLM SIC Summary Email

Other

A Large Language Model-based platform is integrated with the Health Vision Platform, a HIPAA-compliant, electronic health record data management system. Real-time summaries of prior SIC with be sent to clinicians caring for participants in the intervention arm.

An email will be sent to the inpatient attending and responding clinician encouraging the team to review the SIC summary, discuss care preferences with the patient and ensure care is aligned with preferences and goals. If no SIC documentation is found, the email will instead encourage the outpatient oncologist to share information regarding undocumented SICs that may have occurred, as well as prompt inpatient and outpatient teams to engage the patient in SIC.

For patients with no SIC documentation who are still admitted 72 hours later, the RA will send an additional email prompting SIC or asking the clinician to indicate that an SIC is not appropriate. Patients will also receive standard of care.

Primary outcomes

  1. Serious Illness Conversation (SIC) summary accuracy

    Time frame: 1 week

    Primary outcome: We will assess SIC summary accuracy by reviewing the source documentation for each bullet point of the 5 domains of the SIC summary. The RA will read each bullet point, read the source note for the date cited in the summary and indicate with a 1 (supported) or 0 (not supported) whether the documentation supports the summarized point. If a summarized point is scored as 0, the MPIs will independently review the item and assign a 1 or 0 to indicate whether the unsupported summary could negatively impact patient care. SIC summary accuracy will be determined at the patient level as the proportion of bullet points supported by underlying documentation divided by the total number of bullet points (i.e., a score from 0 to 1). We will determine the average SIC accuracy score across all patients for the study. We will also report the percent of LLM-SIC summary statements that are unsupported and clinically significant and provide qualitative descriptions of these instances.

Secondary outcomes

  1. Feasibility (successful delivery of the intervention)

    Time frame: 1 week

    Feasibility is defined as the successful delivery of the summary email, and will be calculated as the number of participants with successful delivery of the intervention email divided by the total number of intervention participants, with an 80% feasibility threshold.

  2. Clinician Perspectives of Clinical Utility

    Time frame: 1 week

    Clinician perspectives of clinical utility are defined as clinicians' views on the usefulness and relevance of serious illness communication (SIC) and, for intervention-arm clinicians, the LLM-generated SIC summaries for informing participant care. These perspectives will be assessed via structured REDCap surveys sent to both inpatient and outpatient clinicians, with follow-up phone interviews conducted by the research assistants for non-respondents.

    Clinician responses to surveys and interview questions will be summarized and stratified by intervention vs control groups. We will compare survey responses between the two study arms using Chisquared and Mann-Whitney U tests for binary and likert items, respectively. Responses to open-ended questions will be qualitatively summarized.

  3. Participant Perspectives on Inpatient and Outpatient Clinician Understanding of their Care Preferences and Acceptability of SIC Summaries

    Time frame: 1 week

    Participant acceptability is defined as participant perceptions of the appropriateness and usefulness of LLM-generated summaries of serious illness conversations (SICs). It will be assessed through structured in-person interviews including the validated "Heard and Understood" questionnaire and open-ended questions regarding the acceptability of SIC summaries and participant-clinician communication.

    Participant responses to interview questions will be summarized and stratified by intervention vs control groups. Responses to open-ended questions will be qualitatively summarized.

  4. New Documentation of SIC

    Time frame: 1 week

    New documentation of serious illness communication (SIC) during the index hospitalization is defined as any new note or entry created in the electronic health record (EHR) during the current hospital admission that reflects a discussion of the participant's values, goals, preferences, or prognosis, and meets the standardized codebook criteria for SIC.

Other outcomes

  1. Length of hospitalization

    Time frame: 1 week

    Length of hospitalization in days for the admission triggering enrollment (data on death during the admission, as well as discharge to hospice and re-admission within 30 days will also be collected)

  2. Days in the hospital

    Time frame: 90 days

    Number of days in the hospital over the subsequent 90 days

  3. Number of hospitalizations

    Time frame: 90 days

    Number hospitalizations over the subsequent 90 days

  4. ICU admissions

    Time frame: 90 days

    Number of intensive care unit admissions over the subsequent 90 days

  5. Intubation

    Time frame: 90 days

    Any occurrence of intubation over the subsequent 90 days

  6. Vital status (including date of death)

    Time frame: 90 days

    Vital status, including date of death, over the subsequent 90 days

Sponsors and collaborators

Lead sponsor

Dana-Farber Cancer Institute

Other

Registry information

Acronym: BRIDGE-SIC

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 28, 2025
Registry last updated
Apr 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.